Clinical Liver Disease

Both nucleos(t)ide analogues (NAs) and pegylated interferon (PEG-IFN) have proven to be effective, but current guidelines are lacking clear recommendations as to which treatment strategy should be used as first-line therapy. The authors review the best available evidence regarding which patients should be treated with interferon.